Mangione’s federal murder trial delayed as state case begins in September

Once scheduled for the fall, the federal murder trial against the man accused of killing UnitedHealthcare CEO Brian Thompson will now begin in January, a judge determined last week.

At the conclusion of a June 29 hearing, U.S. District Judge Margaret Garnett agreed with attorneys representing Luigi Mangione who argued the original date of Oct. 13 left little time to prepare a defense.

A trial in New York on state charges of second-degree murder is set to begin first, with jury selection pegged for a Sept. 8 start date, followed by opening arguments on Oct. 13—the same day the federal trial was initially scheduled to begin. With it now pushed back, Mangione’s attorneys need only worry about the looming prospect their client could be spending the rest of his life in prison as a result of the first trial.

The federal indictment carries the same penalty, after the judge took the death penalty off the table earlier this year, dismissing the more serious murder charges that could have brought capital punishment.

“In my view it’s simply impossible to be moving through the jury selection process in this case while the defendant and his counsel are fully occupied by conducting the state trial,” Garnett said, adding that she had hoped a later date in the fall would be possible—but, the unknowns of the New York proceedings carried the risk of delay.

“[The court] can no longer wait to see what happens,” she stated.

The high profile nature of the case was obvious based on the makeup of the court, as Mangione had supporters in attendance. Commenting on the public nature of the case, Garnett decided that a questionnaire being sent to prospective federal jurors will not be sent out in advance, as the inevitability of it being leaked online and to the media “would only make what promises to be a difficult task more difficult,” she said in reference to a final selection of jurors and alternates.